The Antimicrobial DrugsEric M. Scholar Associate Professor of Pharmacology University of Nebraska College of Medicine, William B. Pratt Professor of Pharmacology University of Michigan Medical School Oxford University Press, USA, 22.05.2000 - 624 Seiten The is the third edition of a text that surveys the drugs used to treat bacterial, fungal, prarsitic, and viral infections. This book contains comprehensive presentations of the mechanisms for both the antimicrobial actions and for the adverse clinical effects of these drugs. Complete discussions of the pharmacology are highlighted by numerous charts and tables summarizing each drug's pharmacokinetic properties and microbial susceptibility. With 3500 reference citations, The Anitmicrobial Drugs provides a complete entry into the literature, making it an invaluable resource for infectious disease specialists, clinical pharmacists, clinical microbiologists, medical students, pharmacy students, and graduate students in pharmacology and microbiology. |
Inhalt
PART 2 DRUGS EMPLOYED IN THE TREATMENT OF BACTERIAL INFECTIONS | 49 |
PART 3 DRUGS EMPLOYED IN THE TREATMENT OF FUNGAL INFECTIONS | 325 |
PART 4 DRUGS EMPLOYED IN THE TREATMENT OF PARASITIC DISEASE | 373 |
PART 5 DRUGS EMPLOYED IN THE TREATMENT OF VIRAL INFECTIONS | 489 |
| 587 | |
Andere Ausgaben - Alle anzeigen
Häufige Begriffe und Wortgruppen
activity acyclovir administered adverse effects Agents Chemother amantadine aminoglycosides amphotericin ampicillin anaerobic antibacterial antibiotics antifungal antimalarial Antimicrob antiviral bacteria bactericidal binding Biochem Biol cause cell wall cephalosporins Chem Chemotherapy chloramphenicol chloroquine Clin clindamycin clinical combination concentrations disease dosage dose drug Engl enzyme erythromycin Escherichia coli ethambutol excreted falciparum fect flucytosine fluid fluoroquinolones ganciclovir gene gentamicin gram-negative griseofulvin half-life hepatic herpes human infections influenza inhibition inhibitors interaction interferon intestinal intravenous isoniazid levels lipid liver malaria mechanism of action mefloquine membrane meningitis metabolism metabolites metronidazole mutations nalidixic acid nephrotoxicity occur oral organisms parasite patients penicillin pharmacokinetics Pharmacol plasma pneumoniae polymerase polymyxin prophylaxis protease quinolones reactions renal resistance ribosomes rifampin sensitive serum ß-lactam ß-lactamase strains Streptococcus streptomycin studies subunit sulfonamides susceptible tetracycline Ther therapeutic therapy tients tion tissue TMP-SMX toxicity tract treat treatment trimethoprim tuberculosis urinary urine vancomycin viral virus viruses vitro zidovudine µg/ml